Virgin Galactic Transaction

Virgin Galactic Holdings, Inc. (“Virgin Galactic”), a space travel company pioneering human spaceflight for private individuals and researchers, successfully completed a recapitalization through a series of privately negotiated debt, equity, and warrant transactions. The transactions significantly strengthened Virgin Galactic’s balance sheet and aligned the Company’s capital structure obligations with its schedule for the design and production of next-generation spacecraft and planned continuation of commercial service.

GLC served as Financial Advisor to Virgin Galactic in connection with the transactions, which closed in late December 2025. The transactions reduced the Company’s outstanding debt from $425mm to $283mm and extended the maturity on most of its debt to late 2028.

As part of the transactions, the Company repurchased and retired $355mm of its $425mm convertible notes due February 2027 for $321mm in cash consideration. Concurrently, the Company issued and sold for cash a combination of $212mm in new first lien notes due December 2028, $46mm in common equity and pre-funded warrants, and $63mm in warrants ($321mm aggregate proceeds) to the institutions that participated in the convertible note repurchase.

GLC Advisors & Co. is a leading independent investment banking advisory firm, delivering objective, senior-level expertise to successfully execute lower middle market to large cap financial advisory engagements for our clients. Founded in 2009, GLC delivers conflict-free counsel on restructurings and other complex or special situation mandates. Today, GLC serves clients in a variety of advisory capacities including mergers & acquisitions, equity and debt capital advisories, restructurings and recapitalizations, fairness opinions, and valuations. Our offices are located in New York, Denver, Los Angeles, and San Francisco.

Jeff Raithel

Jeff Raithel

Managing Director / Los Angeles

John Hill – PENDING

John Hill – PENDING

Director

Alex McLaughlin – PENDING

Alex McLaughlin – PENDING

Associate

Chloe Sileno – PENDING

Chloe Sileno – PENDING

Analyst

Tower Health Transaction

Tower Health (“Tower”), an integrated 1,200-bed regional health system based in Reading, PA, successfully completed a recapitalization through a comprehensive exchange of over $1bn of outstanding bonds and a new $157.5mm financing. The transaction significantly strengthened Tower’s balance sheet, providing sufficient liquidity and runway for Tower to continue its impressive turnaround.

GLC served as Financial Advisor to the Bond Trustee and an ad hoc group of bondholders (the “AHG”) holding more than 84% of Tower’s $1.2bn of outstanding bonds. The public exchange offer was open to all bondholders and was accepted by 92% of outstanding bonds. Concurrently, the AHG and other participating bondholders provided $157.5mm of new financing to bolster Tower’s near-term liquidity.

GLC is a registered Municipal Advisor with the MSRB and SEC and maintains a core focus on the tax-exempt financial markets.

GLC brings a distinctive and dedicated approach to coverage of the Healthcare sector. Our professionals have advised on a range of complex transactions including M&A, debt financing and restructuring & recapitalizations, and our institutional knowledge spans the full spectrum of sub sectors in this constantly evolving industry. Our clients include corporations, creditors, entrepreneurs, and financial sponsors.

Alex Geier

Alex Geier

Managing Director / NYC

Sean Cannon

Sean Cannon

Managing Director / NYC

J. Soren Reynertson

J. Soren Reynertson

Managing Director / NYC

Michael Selling – PENDING

Michael Selling – PENDING

Managing Director

Jason Leshner – PENDING

Jason Leshner – PENDING

Director

David Vige – PENDING

David Vige – PENDING

Associate

Vignesh Maddi – PENDING

Vignesh Maddi – PENDING

Analyst

Joshua Elenowitz – PENDING

Joshua Elenowitz – PENDING

Analyst

Invacare Transaction

GLC Advisors & Co., LLC served as the exclusive financial advisor to the Ad Hoc Committee of Convertible Noteholders (“AHC”) in Invacare’s Chapter 11 restructuring. GLC worked closely with Invacare’s management team and advisors to structure a transaction that reduced the Company’s debt by over $200 million and positioned the business for long-term success. Additionally, the AHC backstopped a $75 million equity rights offering to support the business’ operations. Congratulations to all parties involved in the Company’s emergence from Chapter 11 and a successful transaction!

GLC’s transaction team included Soren Reynertson, Abe Han, Alex Geier, Tim Hagamen, Harper Wathen, Anuj Patel, and Alonso Flores-Noel.

To learn more, please visit our website: www.glca.com

GLC brings a distinctive and dedicated approach to coverage of the Healthcare sector. Our professionals have advised on a range of complex transactions including M&A, debt financing and restructuring & recapitalizations, and our institutional knowledge spans the full spectrum of sub sectors in this constantly evolving industry.

Our clients include corporations, creditors, entrepreneurs, and financial sponsors.

Abe Han

Abe Han

Managing Director / NYC

Alex Geier

Alex Geier

Managing Director / NYC

Tim Hagamen – PENDING

Tim Hagamen – PENDING

Director

Harper Wathen – PENDING

Harper Wathen – PENDING

Director

Anuj Patel – PENDING

Anuj Patel – PENDING

Analyst

Alonso Flores-Noel – PENDING

Alonso Flores-Noel – PENDING

Analyst